Sealing and healing: A two-step model for plasma membrane repair

Area of Science:

• Cell biology
• Neuroscience
• Molecular mechanisms of cell repair

Background:

• Plasma membrane damage is a critical event linked to cell death pathways.
• Such damage is implicated in the pathogenesis of neurodegenerative disorders, including Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).

Purpose of the Study:

• To elucidate the molecular mechanisms underlying plasma membrane repair.
• To investigate the role of annexin A11 (ANXA11) and the ESCRT-III machinery in sealing and removing membrane lesions.
• To determine how mutations associated with ALS and FTD affect these cellular repair processes.

Main Methods:

• Cellular assays to monitor plasma membrane integrity and repair.
• Biochemical and imaging techniques to visualize the recruitment and function of ANXA11 and ESCRT-III components.
• Genetic manipulation to introduce ALS- and FTD-linked mutations into cellular models.

Main Results:

• Annexin A11 (ANXA11) acts as an initial sealant for plasma membrane lesions.
• A sequential, two-step repair mechanism was identified: ANXA11 plugging followed by ESCRT-III mediated removal of the damaged membrane patch.
• Mutations associated with ALS and FTD were found to compromise this two-step membrane repair process, impairing its efficiency.

Conclusions:

• The study reveals a novel two-step mechanism for plasma membrane repair involving ANXA11 and ESCRT-III.
• Dysfunction of this repair pathway due to specific mutations contributes to the cellular pathology of neurodegenerative diseases.
• Targeting this repair mechanism may offer therapeutic strategies for ALS and FTD.